T Cells and Adoptive Immunotherapy: Recent Developments and Future Prospects in Gastrointestinal Oncology

Gastrointestinal oncology is one of the foremost causes of death: the gastric cancer accounts for 10.4% of cancer deaths worldwide, the pancreatic cancer for 6%, and finally, the colorectal cancer for 9% of all cancer-related deaths. For all these gastrointestinal cancers, surgical tumor resection r...

Full description

Saved in:
Bibliographic Details
Main Authors: Amedeo Amedei, Elena Niccolai, Mario M. D'Elios
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Clinical and Developmental Immunology
Online Access:http://dx.doi.org/10.1155/2011/320571
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850170299455111168
author Amedeo Amedei
Elena Niccolai
Mario M. D'Elios
author_facet Amedeo Amedei
Elena Niccolai
Mario M. D'Elios
author_sort Amedeo Amedei
collection DOAJ
description Gastrointestinal oncology is one of the foremost causes of death: the gastric cancer accounts for 10.4% of cancer deaths worldwide, the pancreatic cancer for 6%, and finally, the colorectal cancer for 9% of all cancer-related deaths. For all these gastrointestinal cancers, surgical tumor resection remains the primary curative treatment, but the overall 5-year survival rate remains poor, ranging between 20–25%; the addition of combined modality strategies (pre- or postoperative chemoradiotherapy or perioperative chemotherapy) results in 5-year survival rates of only 30–35%. Therefore, many investigators believe that the potential for making significant progress lies on understanding and exploiting the molecular biology of gastrointestinal tumors to investigate new therapeutic strategies such as specific immunotherapy. In this paper we will focus on recent knowledge concerning the role of T cells and the use of T adoptive immunotherapy in the treatment of gastrointestinal cancers.
format Article
id doaj-art-9f5e628efb91416d9aa61a066f729a86
institution OA Journals
issn 1740-2522
1740-2530
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Clinical and Developmental Immunology
spelling doaj-art-9f5e628efb91416d9aa61a066f729a862025-08-20T02:20:30ZengWileyClinical and Developmental Immunology1740-25221740-25302011-01-01201110.1155/2011/320571320571T Cells and Adoptive Immunotherapy: Recent Developments and Future Prospects in Gastrointestinal OncologyAmedeo Amedei0Elena Niccolai1Mario M. D'Elios2Department of Internal Medicine, University of Florence, Viale Morgagni 85, 50134 Florence, ItalyDepartment of Internal Medicine, University of Florence, Viale Morgagni 85, 50134 Florence, ItalyDepartment of Internal Medicine, University of Florence, Viale Morgagni 85, 50134 Florence, ItalyGastrointestinal oncology is one of the foremost causes of death: the gastric cancer accounts for 10.4% of cancer deaths worldwide, the pancreatic cancer for 6%, and finally, the colorectal cancer for 9% of all cancer-related deaths. For all these gastrointestinal cancers, surgical tumor resection remains the primary curative treatment, but the overall 5-year survival rate remains poor, ranging between 20–25%; the addition of combined modality strategies (pre- or postoperative chemoradiotherapy or perioperative chemotherapy) results in 5-year survival rates of only 30–35%. Therefore, many investigators believe that the potential for making significant progress lies on understanding and exploiting the molecular biology of gastrointestinal tumors to investigate new therapeutic strategies such as specific immunotherapy. In this paper we will focus on recent knowledge concerning the role of T cells and the use of T adoptive immunotherapy in the treatment of gastrointestinal cancers.http://dx.doi.org/10.1155/2011/320571
spellingShingle Amedeo Amedei
Elena Niccolai
Mario M. D'Elios
T Cells and Adoptive Immunotherapy: Recent Developments and Future Prospects in Gastrointestinal Oncology
Clinical and Developmental Immunology
title T Cells and Adoptive Immunotherapy: Recent Developments and Future Prospects in Gastrointestinal Oncology
title_full T Cells and Adoptive Immunotherapy: Recent Developments and Future Prospects in Gastrointestinal Oncology
title_fullStr T Cells and Adoptive Immunotherapy: Recent Developments and Future Prospects in Gastrointestinal Oncology
title_full_unstemmed T Cells and Adoptive Immunotherapy: Recent Developments and Future Prospects in Gastrointestinal Oncology
title_short T Cells and Adoptive Immunotherapy: Recent Developments and Future Prospects in Gastrointestinal Oncology
title_sort t cells and adoptive immunotherapy recent developments and future prospects in gastrointestinal oncology
url http://dx.doi.org/10.1155/2011/320571
work_keys_str_mv AT amedeoamedei tcellsandadoptiveimmunotherapyrecentdevelopmentsandfutureprospectsingastrointestinaloncology
AT elenaniccolai tcellsandadoptiveimmunotherapyrecentdevelopmentsandfutureprospectsingastrointestinaloncology
AT mariomdelios tcellsandadoptiveimmunotherapyrecentdevelopmentsandfutureprospectsingastrointestinaloncology